thiotepa has been researched along with Cystitis in 12 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Cystitis: Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The National Bladder Cancer Group undertook a study to determine the effectiveness and toxicity of mitomycin in patients who failed on thiotepa." | 9.05 | Mitomycin for patients who have failed on thiotepa. The National Bladder Cancer Group. ( Barton, B; Hazra, TA; Heney, NM; Kluskens, L; Koontz, WW; Soloway, MS; Trump, DL, 1985) |
| "Eosinophilic cystitis is a rare form of an allergic cystitis." | 6.39 | Intravesical thiotepa-induced eosinophilic cystitis. ( Choe, JM; Kirkemo, AK; Sirls, LT, 1995) |
| "The National Bladder Cancer Group undertook a study to determine the effectiveness and toxicity of mitomycin in patients who failed on thiotepa." | 5.05 | Mitomycin for patients who have failed on thiotepa. The National Bladder Cancer Group. ( Barton, B; Hazra, TA; Heney, NM; Kluskens, L; Koontz, WW; Soloway, MS; Trump, DL, 1985) |
| "Eosinophilic cystitis is a rare form of an allergic cystitis." | 2.39 | Intravesical thiotepa-induced eosinophilic cystitis. ( Choe, JM; Kirkemo, AK; Sirls, LT, 1995) |
| "Serious leukopenia was found in 2 of the 48 patients receiving the combined instillation therapy but we concluded that this was not attributable to the use of urokinase." | 1.25 | The prophylactic use of thio-tepa and urokinase in transitional cell carcinoma of the bladder: a preliminary report. ( Hisazumi, H; Misaki, T; Miyazaki, K; Naito, K; Uchibayashi, T, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (83.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nissenkorn, I | 1 |
| Slutzker, D | 1 |
| Schujman, E | 1 |
| Servadio, C | 1 |
| Choe, JM | 1 |
| Kirkemo, AK | 1 |
| Sirls, LT | 1 |
| Fleming, RA | 1 |
| Cruz, JM | 1 |
| Webb, CD | 1 |
| Kucera, GL | 1 |
| Perry, JJ | 1 |
| Hurd, DD | 1 |
| Hisazumi, H | 1 |
| Uchibayashi, T | 1 |
| Naito, K | 1 |
| Misaki, T | 1 |
| Miyazaki, K | 1 |
| Koontz, WW | 1 |
| Heney, NM | 1 |
| Soloway, MS | 1 |
| Kluskens, L | 1 |
| Hazra, TA | 1 |
| Trump, DL | 1 |
| Barton, B | 1 |
| Pavone-Macaluso, M | 1 |
| Veenema, RJ | 2 |
| Romas, NA | 1 |
| Fingerhut, B | 1 |
| Mayor, G | 1 |
| Dean, AL | 1 |
| Uson, AC | 1 |
| Roberts, M | 1 |
| Longo, F | 1 |
| Lunglmayr, G | 2 |
| Czech, K | 2 |
2 reviews available for thiotepa and Cystitis
| Article | Year |
|---|---|
Intravesical thiotepa-induced eosinophilic cystitis.
Topics: Adult; Antineoplastic Agents, Alkylating; Cystitis; Eosinophilia; Humans; Male; Thiotepa | 1995 |
Chemotherapy for bladder cancer.
Topics: Administration, Topical; Alkylating Agents; Blood Cell Count; Carcinoma, Papillary; Cystitis; Cystos | 1974 |
2 trials available for thiotepa and Cystitis
| Article | Year |
|---|---|
Urinary elimination of cyclophosphamide alkylating metabolites and free thiols following two administration schedules of high-dose cyclophosphamide and mesna.
Topics: Adult; Antineoplastic Agents, Alkylating; Carboplatin; Cyclophosphamide; Cystitis; Drug Administrati | 1996 |
Mitomycin for patients who have failed on thiotepa. The National Bladder Cancer Group.
Topics: Administration, Topical; Biopsy; Carcinoma in Situ; Clinical Trials as Topic; Cystitis; Cystoscopy; | 1985 |
8 other studies available for thiotepa and Cystitis
| Article | Year |
|---|---|
The influence of lower urinary tract infection on the recurrence rate of superficial transitional cell carcinoma of the bladder.
Topics: Aged; Animals; Anti-Bacterial Agents; Carcinoma, Transitional Cell; Cystitis; Dogs; Female; Humans; | 1983 |
[Bladder tumors].
Topics: Carcinoma in Situ; Cystitis; Diagnosis, Differential; Doxorubicin; Humans; Thiotepa; Urinary Bladder | 1981 |
The prophylactic use of thio-tepa and urokinase in transitional cell carcinoma of the bladder: a preliminary report.
Topics: Adolescent; Adult; Aged; Carcinoma, Transitional Cell; Cystitis; Drug Therapy, Combination; Endopept | 1975 |
Chemotherapy of vesical and prostatic tumours.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Cobalt Isotopes; Cystitis; Daunorubic | 1971 |
[Bladder lesions due to local administration or ingestion of antiseptic, cytostatic and radioactive compounds].
Topics: Anti-Infective Agents, Urinary; Antineoplastic Agents; Cresols; Cystitis; Humans; Iodine Radioisotop | 1973 |
Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors.
Topics: Blood Platelet Disorders; Cystitis; Cystoscopy; Humans; Leukopenia; Neoplasm Recurrence, Local; Solu | 1969 |
[Experimental animal and clinical studies of the absorption of trisaziridylthiophosphoric acid (Thio-Thepa) from the bladder].
Topics: Absorption; Animals; Cystitis; Humans; Male; Papilloma; Rabbits; Thiotepa; Urinary Bladder; Urinary | 1970 |
Absorption studies on intraluminal thio-tepa for topical cytostatic treatment of low-stage bladder tumors.
Topics: Body Fluids; Bone Marrow; Cystitis; Epithelium; Humans; Methods; Papilloma; Pyridines; Thiotepa; Uri | 1971 |